Entity Common Stock, Shares Outstanding of Xenon Pharmaceuticals Inc. from 30 Nov 2014 to 30 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Xenon Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Nov 2014 to 30 Oct 2025.
  • Xenon Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending 30 Oct 2025 was 77,275,005, a 1.4% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Xenon Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 77,275,005 +1,035,403 +1.4% 30 Oct 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 77,105,799 +1,341,294 +1.8% 07 Aug 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 76,542,811 +1,110,329 +1.5% 24 Feb 2025 10-K 27 Feb 2025 2024 FY
Q3 2024 76,239,602 +10,809,891 +17% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 75,764,505 +11,618,982 +18% 05 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 75,432,482 +11,870,179 +19% 26 Feb 2024 10-K 29 Feb 2024 2023 FY
Q3 2023 65,429,711 +2,885,692 +4.6% 03 Nov 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 64,145,523 +1,882,060 +3% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 63,562,303 +11,640,857 +22% 05 May 2023 10-Q 09 May 2023 2023 Q1
Q3 2022 62,544,019 +10,954,740 +21% 04 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 62,263,463 +21,139,279 +51% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 51,921,446 +16,112,199 +45% 25 Feb 2022 10-K 01 Mar 2022 2021 FY
Q3 2021 51,589,279 +16,581,913 +47% 08 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 41,124,184 +6,129,238 +18% 09 Aug 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 35,809,247 +852,975 +2.4% 26 Feb 2021 10-K 01 Mar 2021 2020 FY
Q3 2020 35,007,366 +9,138,410 +35% 03 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 34,994,946 +9,219,890 +36% 04 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 34,956,272 +9,205,006 +36% 05 Mar 2020 10-K 09 Mar 2020 2019 FY
Q3 2019 25,868,956 +628,608 +2.5% 01 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 25,775,056 +6,513,167 +34% 02 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 25,751,266 +7,748,767 +43% 01 Mar 2019 10-K 06 Mar 2019 2018 FY
Q3 2018 25,240,348 +7,241,928 +40% 02 Nov 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 19,261,889 +1,263,469 +7% 03 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 18,002,499 +66,517 +0.37% 02 Mar 2018 10-K 07 Mar 2018 2017 FY
Q3 2017 17,998,420 +105,116 +0.59% 03 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 17,998,420 +3,572,050 +25% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 17,935,982 +3,534,400 +25% 03 Mar 2017 10-K 08 Mar 2017 2016 FY
Q3 2016 17,893,304 +3,517,086 +24% 28 Oct 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 14,426,370 +139,512 +0.98% 29 Jul 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 14,401,582 +179,982 +1.3% 04 Mar 2016 10-K 08 Mar 2016 2015 FY
Q3 2015 14,376,218 02 Nov 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 14,286,858 07 Aug 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 14,221,600 09 Mar 2015 10-K 12 Mar 2015 2014 FY
Q4 2014 14,181,333 30 Nov 2014 10-Q 15 Dec 2014 2014 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.